Andere Sprachen Bio-Thera Solutions, Ltd.

Aktien

688177

CNE100003R98

688177

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
33,12 ^CNY	-0,51 %		+14,21 %	-19,69 %

29.04.	Bio-Thera Solutions, Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
25.03.	Bio-Thera Solutions erhält IND-Genehmigung von der US FDA für den Beginn einer Phase II-Studie für BAT8006	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
Bio-Thera Solutions Receives IND Clearance from US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor	26.03.
Bio-Thera Solutions Receives IND Clearance From US FDA to Initiate a Phase II Study for BAT8006	25.03.
Bio-Thera Solutions Grants Marketing Rights of Two Drugs to Latin American Company	20.03.
Bio-Thera Solutions, Ltd. Partners with SteinCares to Market Two Biosimilars in LATAM	18.03.
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23.02.
Bio-Thera Solutions Announces Initiation of Phase IB / IIA Clinical Trial for BAT6026	01.02.
Bio-Thera Solutions Gets Regulatory Nod for Trial of Tumor Drug Combination Treatment	12.01.
Recent Biosimilar Approvals	21.12.
Sandoz pourra distribuer aux USA un biosimilaire chinois de l'Avastin de Roche	08.12.
Bio-Thera Solutions Wins US FDA Nod to Market Cancer Drug	08.12.
FDA Approves Bio-Thera Solutions' Avzivi (Bevacizumab-Tnjn), A Biosimilar Referencing Avastin	07.12.
Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara	29.11.
Bio-Thera Solutions, Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Chugai Pharmaceutical Co., Ltd. - Notice of the Settlement of Patent Infringement Litigation in the U.S	25.10.23
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement	24.10.23
Roche, Biogen Settle US Patent Infringement Case Over Actemra Biosimilar	24.10.23
Roche settles US patent lawsuit against Biogen over blockbuster arthritis drug	23.10.23
Bio-Thera Partner Gets US FDA Marketing Nod for Arthritis Injectable	09.10.23
FDA Approves Bio-Thera Solutions, Ltd.'s Partner Biogen Receives Notification from the United States Food and Drug Administration	08.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Thera Solutions, Ltd.

Aktien

688177

CNE100003R98

688177

Andere Sprachen

Filter